Latest Breaking News On - Kiniksa pharmaceuticals ltd - Page 7 : comparemela.com

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Up to $20 89

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $20.89, but opened at $21.92. Kiniksa Pharmaceuticals shares last traded at $19.81, with a volume of 99,193 shares. Analysts Set New Price Targets KNSA has been the topic of several analyst […]

Johnf paoliniMichaelr megnaNews ratings for kiniksa pharmaceuticals dailyGroup plcMercer global advisors incOpaleye management incKiniksa pharmaceuticals ltdParkman healthcare partnersSecurities exchange commissionInstitutional trading of kiniksa pharmaceuticalsKiniksa pharmaceuticals stock downKiniksa pharmaceuticalsGet free reportPharmaceuticals stock downExchange commissionGlobal advisors

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Earns Outperform Rating from Wedbush

Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Wedbush in a research report issued to clients and investors on Wednesday, RTT News reports. They presently have a $28.00 price objective on the stock. Wedbush’s price objective would suggest a potential upside of 37.52% from the company’s […]

Johnf paoliniMark ragosaKiniksa pharmaceuticals trading downLinden thomas advisory servicesKiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyHedge funds weigh in on kiniksa pharmaceuticalsKiniksa pharmaceuticals company profileAllspring global investments holdingsConnor clark lunn investment management ltdKiniksa pharmaceuticals ltdPrincipal financial group incGet free reportPharmaceuticals trading downGlobal investments holdingsThomas advisory services

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20 94

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20 94
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Johnf paoliniMark ragosaSecurities exchange commissionYork mellon corpKiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyCharles schwab investment management incTejara capital ltdKiniksa pharmaceuticals ltdInsider activity at kiniksa pharmaceuticalsGroup plcKiniksa pharmaceuticals price performanceGet free reportExchange commissionNew york mellon corpGeneral group plc

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 12-Month High at $20 94

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Sets New 12-Month High at $20 94
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelr megnaJohnf paoliniKiniksa pharmaceuticalsSecurities exchange commissionBlackrock incMorgan stanleyKiniksa pharmaceuticals company profileVanguard group incNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticals ltdKiniksa pharmaceuticals tradingGet free reportExchange commissionCapital managementStreet corpKiniksa pharmaceuticals daily

Dark Forest Capital Management LP Buys New Stake in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)

Dark Forest Capital Management LP Buys New Stake in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Mark ragosaZurcher kantonalbank zurich cantonalbankJohnf paoliniKiniksa pharmaceuticals ltdYork mellon corpCharles schwab investment management incNews ratings for kiniksa pharmaceuticals dailyQuarter for kiniksa pharmaceuticalsKiniksa pharmaceuticalsGroup plcRoyal bankExchange commissionKiniksa pharmaceuticals profileKiniksa pharmaceuticals stock performanceDark forest capital managementFree report